In the pharmaceutical industry, contract updates, chargeback claims and credits are shared between trading partners through EDI 845, EDI 844 and EDI 849. Due to reliance on these EDI messages, roughly 4% of chargebacks result in errors causing revenue leakage, cash flow delays, and manual effort for everyone.
This guide explains why the time has come to move beyond EDI to blockchain-based solutions in pharma contracting and chargebacks.
This quick 2-min video offers an excellent overview to learn more about the Contracts & Chargebacks solution on the MediLedger Network.
